Edgar Pérez-Herrero
Biomaterials · 2015
A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomaterials — 50 citations into it
- Molecular Biology — 49 citations into it
- Biomedical Engineering — 33 citations into it
- Oncology — 20 citations into it
- Organic Chemistry — 5 citations into it
Whom Edgar Pérez-Herrero trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Edgar Pérez-Herrero's perspective
Ordered by how strongly the researchers Edgar Pérez-Herrero trusts endorse each paper. Same corpus, a different order for every researcher.
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Nanoparticles for drug delivery in cancer treatment. (Urologic oncology)
- Drug Delivery Systems: Entering the Mainstream (Science)
- Cancer nanotechnology: opportunities and challenges (Nature Reviews. Cancer)
- Active targeting schemes for nanoparticle systems in cancer therapeutics. (Advanced Drug Delivery Reviews)
- Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. (Journal of the National Cancer Institute)
- Polymer conjugates as anticancer nanomedicines (Nature Reviews. Cancer)
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
Their papers
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. (2015) — 1,606 citations